產(chǎn)品展示
Anti-PIBF(progesterone induced blocking factor)孕激素誘導(dǎo)阻斷因子抗體
點(diǎn)擊次數(shù):17發(fā)布時(shí)間:2016/7/23 14:57:40

更新日期:2016/7/23 14:57:40
所 在 地:中國(guó)大陸
產(chǎn)品型號(hào):
優(yōu)質(zhì)供應(yīng)
詳細(xì)內(nèi)容
【Anti-PIBF(progesterone induced blocking factor)孕激素誘導(dǎo)阻斷因子抗體】齊一生科技(上海)有限公司感謝您的查閱與咨詢!期待與您的真誠(chéng)合作!
低價(jià)格現(xiàn)貨供應(yīng),歡迎前來選購齊一生物銷售:021-6034 8496;181214 53965;173021 04490網(wǎng)站:www.qiyibio.com【Anti-PIBF(progesterone induced blocking factor)孕激素誘導(dǎo)阻斷因子抗體】
QY-x2364 293T人胚腎細(xì)胞293T含1.5g/L 碳酸氫鈉, 4.5g/L 葡萄糖, 4mM L-谷氨酰胺的DMEM,90%;胎牛血清,10%。 : 293細(xì)胞株插入...
QY-x2365 22RV1人前列腺癌細(xì)胞 含10mM HEPES, 1mM 丙酮酸鈉,4.5g/l 葡萄糖和1.5g/l碳酸氫鈉和2mM L-谷氨酰胺的RPMI 1640;
QY-x2366 5637人膀胱癌細(xì)胞 膀胱;癌形態(tài): /年齡: 含1.5g/L 碳酸氫鈉, 4.5g/L 葡萄糖, 10mM HEPES,1.0mM丙酮酸鈉,和2mM L-谷氨酰胺的RPMI 16...
QY-x2367 293 人胚腎細(xì)胞腎;以腺病毒5 DNA 進(jìn)行轉(zhuǎn)化。 含 1.5g/L 碳酸氫鈉,0.1mM 非必需氨基酸,1.0mM 丙酮酸鈉,2mM L-谷氨酰胺和Earle&...
QY-x2368 大鼠肝細(xì)胞BRL
QY-x2369 人肝母細(xì)胞瘤細(xì)胞HUH-6
QY-x2370 小鼠淋巴瘤細(xì)胞YAC-1 【Anti-PIBF(progesterone induced blocking factor)孕激素誘導(dǎo)阻斷因子抗體】
QY-x2371 人羊膜細(xì)胞WISH
QY-x2372 人胚肺細(xì)胞WI-38
QY-x2373 非洲綠猴腎細(xì)胞Vero
QY-x2374 細(xì)胞淋巴瘤細(xì)胞U-937
QY-x2375 人腦星形膠質(zhì)母細(xì)胞瘤U-87MG
QY-x2376 人膠質(zhì)瘤細(xì)胞U251
QY-x2377 人骨肉瘤細(xì)胞U-2OS
QY-x2378 單核細(xì)胞系THP-1
QY-x2379 人血液白血病細(xì)胞TF-1
QY-x2380 人舌鱗癌細(xì)胞Tca-8113
QY-x2381 蝙蝠肺細(xì)胞Tb1Lu
QY-x2382 人乳腺管癌細(xì)胞T-47D
QY-x2383 人膀胱移行細(xì)胞癌細(xì)胞T-24
QY-x2384 人結(jié)腸癌細(xì)胞SW620
QY-x2385 人甲狀腺鱗癌細(xì)胞SW579
QY-x2386 人結(jié)腸癌細(xì)胞SW[SW-] 【Anti-PIBF(progesterone induced blocking factor)孕激素誘導(dǎo)阻斷因子抗體】
QY-x2387 豬睪丸細(xì)胞系ST
QY-x2388 小鼠骨髓瘤細(xì)胞SP2/0
QY-x2389 人肝癌細(xì)胞SMMC-7721
QY-x2390 人卵巢癌細(xì)胞SK-OV-3
QY-x2391 人肝癌細(xì)胞SK-HEP-1
QY-x2392 人乳腺腺癌細(xì)胞SK-BR-3
QY-x2393 人子宮頸鱗癌細(xì)胞SiHa
QY-x2394 人膠質(zhì)瘤細(xì)胞SHG-44
QY-x2395 人胃癌SGC7901
9242546 Probe Holder Assembly, LX200, LC CNY
9242152 Upgrade, CAS1820 vacuum DX/VX "The Upgrade, CAS 1820 vacuum DX/VX upgrades the X-tractorgene to use the improved vacuum system for the QIAxtractor. The upgrade is conducted as an on-site service, performed by a QIAGEN service specialist.
The upgrade allows for the usage of the QIAGEN DX and VX capture plates and the disposable silicon mats.
During the service, the new vacuum system is installed and the software is updated. Please note that due to the software upgrade the instrument will only run the QIAxtractor software applications. Customized run files from the previous version will have to be adapted beforehand for additional fees." CNY
5000-1404 Plate Cartridge 110V, VTX2 CNY
5000-1277 Top Housing W LID, DML2 CNY
5050-1029 Mouse, PC System spare CNY
5025-1011 Expand 4 Pipettor 240V CNY
9240747 Belt, Reagent Pump 117 groove, AP CNY
9240720 Cable Carrier, Tubing, Dispense Head, AP CNY
9240700 Tubing, Waste, 1 1\4", AP CNY
9243690 DML Luminometer, Repair Fee DML Repair Fee covers Regional Repair Center service for non-service agreement covered DML 2000 and DML 3000 units. Includes labor, parts and shipping materials. CNY
9243652 Comprehen Valid., QuantiPlex/QP Hyres """The Comprehensive Validation Support plan specific to a laboratory's needs will incorporate all of the requirements for the internal validation guidelines from the FBI's Quality Assurance Standards (QAS).
The Comprehensive Validation Support service includes all travel and labor charges for up to 20 days by the QIAGEN Validation Team. Typically, one week will be required to extract, quantify, and amplify the validation study samples and may require multiple individuals. Usually, two weeks is required to analyze the data and one week to write the final report. The expected time period to complete the Comprehensive Validation is six weeks. The actual time may vary depending on resource availability, including laboratory time dedicated to validation activities.
Lab Work – The QIAGEN specialist(s) will travel to the laboratory to conduct the on-site validation lab work. The QIAGEN specialist team will perform and complete all extractions, quantifications, amplfications, and capillary electrophoresis. The laboratory is responsible for providing systems/protocols that may be needed (generally laboratory SOPs, ex. interpretation guidelines). Additionally, the laboratory staff may be required to provide additional data needed for interpretation (ex. quantification/amplification/CE results) during the data review phase of the validation.
Once the final scope of the validation is determined, QIAGEN will provide a quote for all consumables required for the validation. Non-QIAGEN chemistry and accessories are not included and should be purchased to cover the validation experimental design including qPCR, STR, NIST standards, required samples types (blood, semen, buccal samples) and required substrates (swabs, materials, etc). For planning purposes and to ensure a smooth process, the Customer is expected to have all materials on-hand and inventoried one (1) week prior to the validation start date.
Data Analysis – The Comprehensive Validation Support plan encompasses data collection (quants, amps, CE) during the on-site visit. The laboratory may be responsible for sharing (typically electronically via e-mail) any validation data requested after the on-site visit. A QIAGEN specialist will complete all of the data analysis produced from the validation study design. This includes qPCR (quant) and STR (amp) analysis and linkage to starting samples.
Validation data CD/flashdrive – QIAGEN will review the validation data and draft a validation summary document, ensuring compliance with the FBI's QAS requirements/standards. QIAGEN will send validation data in an electronic format (email/CD/flashdrive) to the laboratory. The laboratory is responsible for final compilation, any format change preferences, review and signoff of the validation report. The documentation provided by QIAGEN will aide in demonstrating compliance with all accreditation guidelines during laboratory audits. Should a hard copy of the validation study be preferred, the laboratory is required to specify prior to the onset of the validation.
Post-validation QIAGEN-to-Laboratory Transfer – Following completion of the validation and generation of the draft validation summary document, a designated member of the QIAGEN validation team will review the validation with the Lab Manager and the Technical Leader. Following sign off on the validation report, training of the laboratory DNA staff will occur. Refer to the Post-validation Competency Training for additional information. """ CNY 【Anti-PIBF(progesterone induced blocking factor)孕激素誘導(dǎo)阻斷因子抗體】
6000-3101 Rapid Capture System CNY
19134 QIAGEN Proteinase K CNY
614033 careHPV Test, SFDA (24-test) CNY
274203 flocktype IBDV Ab (5) CNY
270803 cattletype MAP Ab (5) CNY
280303 cador BVDV RT-PCR Kit (24) CNY
282303 virotype PRRSV RT-PCR Kit (24) CNY
282305 virotype PRRSV RT-PCR Kit (96) CNY
280443 virotype BTV pan/8 RT-PCR Kit (24) CNY
939012 Buffer N2 (2 x 10 ml) CNY
871105 EGFR PCR Kit (100) CNY
800382 Restriction Map CNY
871005 KRAS PCR Kit (100) CNY
9020586 Power Supply, 24V 60W, DML 3000 CNY
9013314 Shaker adapter, 192-tube, 5 ml CNY
9013211 Cabling kit, data, BR8000 CNY 【Anti-PIBF(progesterone induced blocking factor)孕激素誘導(dǎo)阻斷因子抗體】
9011747 Worktable left, BR8000 v1.01 CNY
132568 NeXtal Stock Methoxy-PEG 5000 (50) 30% w/v Methoxypolyethylene glycol 5000 - 50mL (4 x 12,5 ml tube) CNY
800311 Custom Primer CNY